Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Snap Inc (SNAP) vs TransMedics Group Inc (TMDX) Price & Performance

TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Snap Inc vs TransMedics Group Inc — how do they compare? Snap Inc trades at $5.28 (market cap $9.32B), while TransMedics Group Inc trades at $87.56 (market cap $3.10B). The key difference: Snap Inc is far larger — about 3× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.

SNAPTMDX
Market Cap
$9.32B$3.10B
Sector
MediaTechnology
52-Week High
$9.09$150.42
52-Week Low
$3.93$61.99
Enterprise Value
$10.88B$3.49B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Snap Inc

Snap Inc. (SNAP) trades at $5.34, up 0.19% today, with a bullish technical signal from moving averages. The company shows improving fundamentals with Q2 2026 revenue growth of 19% year-over-year to $1.60 billion and a narrowing net loss, beating analyst expectations. Operating cash flow strengthened to $656 million in 2025, while the stock trades below the consensus price target of $7.02 with 38% of analysts rating it a buy.

The outlook suggests potential upside from continued advertising revenue growth and cost discipline, but risks include persistent net losses, high debt levels, and competitive pressures in social media. Investor sentiment is cautiously optimistic amid earnings beats and insider selling activity.

TransMedics Group Inc

TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.

Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Snap Inc

Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.

Read more on SNAP

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX